Jonathan Javitt
Listed on 1 Form D filing across 1+ issuer
· Executive Officer
Associated issuers
- NRX Pharmaceuticals, Inc. CIK 1719406 · DE
Filings (1)
-
NRX Pharmaceuticals, Inc.D · 2025-03-07 · DE · Biotechnology$3.5Mview →